Fertiliteitsdiagnostiek anno 2011

44
Fertiliteitsdiagnostiek anno 2011 Willem Ombelet Genk Gent, 12-05-2011 Gent, 12-05-2011

description

Fertiliteitsdiagnostiek anno 2011. Willem Ombelet Genk. Gent, 12-05-2011. 10-15 % van de koppels met kinderwens hebben fertiliteitsproblemen Oorzaken 30% man 30% vrouw 30% man & vrouw 10% onbekend. Spermatogenesis. Female Male. Serum: infections, hormonal, thyroid, AMH. - PowerPoint PPT Presentation

Transcript of Fertiliteitsdiagnostiek anno 2011

Page 1: Fertiliteitsdiagnostiek  anno 2011

Fertiliteitsdiagnostiek anno 2011Fertiliteitsdiagnostiek anno 2011

Willem OmbeletGenk

Willem OmbeletGenk

Gent, 12-05-2011Gent, 12-05-2011

Page 2: Fertiliteitsdiagnostiek  anno 2011

10-15 % van de koppels met kinderwens hebben 10-15 % van de koppels met kinderwens hebben fertiliteitsproblemenfertiliteitsproblemen

Oorzaken Oorzaken 30% man30% man 30% vrouw30% vrouw 30% man & vrouw30% man & vrouw 10% onbekend10% onbekend

Page 3: Fertiliteitsdiagnostiek  anno 2011
Page 4: Fertiliteitsdiagnostiek  anno 2011
Page 5: Fertiliteitsdiagnostiek  anno 2011

Spermatogenesis

Page 6: Fertiliteitsdiagnostiek  anno 2011

Female Male

Serum: infections, hormonal, thyroid, AMH Serum: infections, hormonalSemen sample

FSHPrl

HSGHysteroscopy

E2, Prog, LH

PCT

US uterus & ovaries

E2, Prog

0menses

2-3 14 28

Outpatient

LaparoscopyCT, MRI, ... Treatment

repeat semen sample US + Doppler scrotumGenetics

Page 7: Fertiliteitsdiagnostiek  anno 2011

Oorzaken: vrouwOorzaken: vrouw

BaarmoederhalsfactorBaarmoederhalsfactor zz zz ImplantatiestoornisImplantatiestoornis

Syndr v AshermanSyndr v Asherman Poliepen, myomen, infectiesPoliepen, myomen, infecties

EileiderfactorenEileiderfactoren SterilisatieSterilisatie post-infectiepost-infectie erge endometrioseerge endometriose

EisprongstoornissenEisprongstoornissen PCOPCO hyperprolactinemiehyperprolactinemie

Andere afwijkingenAndere afwijkingen Post-heelkundePost-heelkunde

Page 8: Fertiliteitsdiagnostiek  anno 2011

Meest frequente vrouwelijke factorAnovulatie

Meest frequente vrouwelijke factorAnovulatie

Oligomenorree (cyclus > 35 d)

Amenorree Primair (XO - syndr v Turner)Primair (XO - syndr v Turner) SecundairSecundair

normogonadotroop (hyperprolactinemie) hypogonadotroop hypergonadotroop (PCO – syndroom)

Page 9: Fertiliteitsdiagnostiek  anno 2011

Hypogonadotrope amenorreeHypogonadotrope amenorree

stress, vermagering, sportstress, vermagering, sport

Simple weight loss amenorreeSimple weight loss amenorree

Exercise-associated amenorreeExercise-associated amenorree

Psychogene hypothalame amenorreePsychogene hypothalame amenorree

Lage E2, laag FSH en LH, hoog cortisolLage E2, laag FSH en LH, hoog cortisol

Page 10: Fertiliteitsdiagnostiek  anno 2011

Hyperprolactinemie

Page 11: Fertiliteitsdiagnostiek  anno 2011

Oligo- of anovulatie

Hyperandrogenisme

PCO-echografisch

PCO - Syndroom

Cyclus > 35 dagen

Hirsutisme, haaruitvalAcne

testosterone

12 follikels < 10mm – bilatOf

Ovarieel volume > 10 ml( 0.5233 x L x B x H )

Page 12: Fertiliteitsdiagnostiek  anno 2011

Ovariële reserveOvariële reserve

Pro

po

rtio

n o

f p

oo

r q

ual

ity

oo

cyt

es(%

)102

103

104

105

106

Nu

mb

er o

f fo

llicl

es

107

0 10 20 30 40 50 60

50

75

100

25

Age (years)

Optimalfertility Declining

fertility End of fertility

Irregularcycles

Number of follicles

Proportion of poor quality oocytes

Menopause

100

Female Age (yrs)

0

50

25

75

41 51 6121

Cu

mu

lati

ve %

31

Men

opa

use

On

set

Irre

gu

lari

ty

Ste

rilit

y

Su

bfe

rtili

ty

46

Website: www.fvvo.beBroekmans, FV&V in ObGyn, 2009, 2, 79-89

Page 13: Fertiliteitsdiagnostiek  anno 2011

Accuracy Non Pregnancy prediction

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1

1 - Specificity

Se

ns

itiv

ity

sROC curve AFC sROC curve AMH sROC curve FSHAFC studiesAMH studiesFSH studies

Accuracy Poor Response prediction

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1

1 - Specificity

Se

ns

itiv

ity

sROC curve AFC

sROC curve AMH

AFC studies

AMH studies

Broekmans, FV&V in ObGyn, 2009, 2, 79-89

Page 14: Fertiliteitsdiagnostiek  anno 2011

Cavum- en tubapathologieCavum- en tubapathologie

Page 15: Fertiliteitsdiagnostiek  anno 2011

Female Male

Serum: infections, hormonal, thyroid Serum: infections, hormonalSemen sample

FSHPrl

HSGHysteroscopy

E2, Prog, LH

PCT

US uterus & ovaries

E2, Prog

0menses

2-3 14 28

Outpatient

LaparoscopyCT, MRI, ... Treatment

repeat semen sample US + Doppler scrotumGenetics

Page 16: Fertiliteitsdiagnostiek  anno 2011
Page 17: Fertiliteitsdiagnostiek  anno 2011

HSG: unicornuate uterus, patent tube

MRI: unicornuate uterus

MRI: ectopic ovary anterior to the

external iliac vessels

Page 18: Fertiliteitsdiagnostiek  anno 2011

Ombelet et al., N Engl J Med, 348, 667, 2003

Page 19: Fertiliteitsdiagnostiek  anno 2011

Diagnostische Hysteroscopie Diagnostische Hysteroscopie

Page 20: Fertiliteitsdiagnostiek  anno 2011

LaparoscopieLaparoscopie

Page 21: Fertiliteitsdiagnostiek  anno 2011
Page 22: Fertiliteitsdiagnostiek  anno 2011

Female Male

Serum: infections, hormonal, thyroid Serum: infections, hormonalSemen sample

FSHPrl

HSGHysteroscopy

E2, Prog, LH

PCT

US uterus & ovaries

E2, Prog

0menses

2-3 14 28

Outpatient

LaparoscopyCT, MRI, ... Treatment

repeat semen sample US + Doppler scrotumGenetics

Page 23: Fertiliteitsdiagnostiek  anno 2011

WHO 1987: 3555 men with male factorWHO 1987: 3555 men with male factor

Page 24: Fertiliteitsdiagnostiek  anno 2011

Normaal : ≥20 mill / ml

Oligozoospermie : < 20 mill / ml

Asthenozoospermie : < 25 % grade a< 50 % grade a + b

Teratozoospermie : < 30 % < 14 % (strict criteria)

WHO 1999 : “authority-based” // not “evidence-based”

Page 25: Fertiliteitsdiagnostiek  anno 2011

Case-control studyCase-control study

143 fertile

Men from pregnant women < 20 weeks

144 subfertileExclusion: tubal factor & anovulation

ProspectiveProspectivestudystudy

Statistics: ROC analysis

W Ombelet et al, Hum Reprod, 12, 987-993, 1997

Page 26: Fertiliteitsdiagnostiek  anno 2011

ResultsResultsResultsResults

Area (ROC)Area (ROC) Cut-off ROCCut-off ROCP10 (F)P10 (F)

Count 69.4 34 14.3

Motility (a+b) 60.9 45 28

Morphology 77.7 10 5

Page 27: Fertiliteitsdiagnostiek  anno 2011

WHO 2010

4500 men / TTP< 12 months/ P4500 men / TTP< 12 months/ P55

VolumeVolume < 1.5 ml< 1.5 ml

Sperm concentrationSperm concentration < 15 million spermatozoa/ml< 15 million spermatozoa/ml

Total Sperm numberTotal Sperm number < 39 million spermatozoa< 39 million spermatozoa

MotilityMotility (grade A+B) (grade A+B) < 32 % progressive motile< 32 % progressive motile

MorphologyMorphology < 4 % normal< 4 % normal

VitalityVitality < 58 %< 58 %

Cooper et al., HRU, 16, 231-245, 2010

Page 28: Fertiliteitsdiagnostiek  anno 2011

TUNEL assay. TUNEL-positive nuclei (with double-strand nuclear DNA fragmentation) of spermatozoa as represented by the intense (A) and dull (B) Texas red fluorescence in

the nuclear region. The healthy nuclei (without DNA fragmentation) are stained blue with DAPI (C) used as counterstain.

Angelopoulou et al., Reprod Biol Endocrinol, 5, 36, 2007

Sperm Chromatin Structure Assay – SCSA

100

1000

Gre

en

Flu

ore

scen

ce

Evenson et al., 1980

200 cells /minute5000 cells analysed/sample

Denatured ss DNA: red fluorescence

Page 29: Fertiliteitsdiagnostiek  anno 2011

Tubal Factor No Tubal Factor

IMC< 1 million

Morphology < 4%

ICSI

IVF

IMC< 1 million

Morphology >= 4%

IMC>= 1 million

Washingprocedure

IMC< 1 million

Morphology < 4%

ICSI

IUI 4 x

IMC< 1 million

Morphology >= 4%

IMC>= 1 million

Washing procedure

Initial SemenSample

Algorithm for male subfertility treatment

< 30% or no fertilisation

< 30% or no fertilisation

ICSI

IVF

Page 30: Fertiliteitsdiagnostiek  anno 2011

Semen profile in a general population Aim: to investigate sperm quality in a general populationAim: to investigate sperm quality in a general population

Semen profile in a general population Aim: to investigate sperm quality in a general populationAim: to investigate sperm quality in a general population

Website: www.fvvo.beOmbelet et al., FV&V in ObGyn, 2009, 1, 18-26

Page 31: Fertiliteitsdiagnostiek  anno 2011
Page 32: Fertiliteitsdiagnostiek  anno 2011

Azoospermia: etiologyAzoospermia: etiologyAzoospermia: etiologyAzoospermia: etiology

Non-obstructive

Maturation arrest Idiopathic, cryptorchidism, Idiopathic, cryptorchidism,

mumps, drugs …mumps, drugs …

Sertoli cell only Idiopathic, irridiation, Idiopathic, irridiation,

drugs …drugs …

Seminiferous tubular sclerosis

Genetic, Klinefelter, Genetic, Klinefelter, testicular torsion, …testicular torsion, …

Obstructive

Epididymal obstruction Post-infective, post-surgery,

Vas deferens obstruction CBAVD, post-vasectomy ..

Ejaculatory duct obstruction

Prostatic cysts, post-surgical, post-infective

Page 33: Fertiliteitsdiagnostiek  anno 2011

Azoospermia: diagnosisAzoospermia: diagnosisAzoospermia: diagnosisAzoospermia: diagnosis

Non-obstructive

Genetic testingGenetic testing

FSH, FSH, inhibine Binhibine B

testicular volumetesticular volume

Obstructive

Genetic testingGenetic testing

FSH, inhibine B: nlFSH, inhibine B: nl

testicular volume: nltesticular volume: nl

Page 34: Fertiliteitsdiagnostiek  anno 2011

KaryotypeKaryotype

Count < 5 millCount < 5 mill

Page 35: Fertiliteitsdiagnostiek  anno 2011

Yq deletionsYq deletions13% if nonobstructive azoospermia13% if nonobstructive azoospermia3 - 7% with severe oligozoospermia3 - 7% with severe oligozoospermia““Transmitted to male offspring”Transmitted to male offspring”

AZFa, AZFb,AZFa, AZFb, AZFb +c,AZFb +c, YqYq deletionsdeletions

All azoospermicAll azoospermicNone with sperm onNone with sperm on

diagnostic biopsy or TESEdiagnostic biopsy or TESE

AZFc deletionsAZFc deletions27/42 severely oligospermic27/42 severely oligospermic

9/20 (45%) with sperm on biopsy9/20 (45%) with sperm on biopsy9/12 (75%) had sperm at TESE9/12 (75%) had sperm at TESE

Hopps et al, HR, 18, 1660, 2003

Page 36: Fertiliteitsdiagnostiek  anno 2011

EVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIA

AzoospermiaAzoospermia

VasectomyVasectomy EndocrineEndocrineevaluationevaluation

<< 15 years 15 years

Vas reversalVas reversal

HypogonadotropicHypogonadotropichypogonadismhypogonadism

Semen volumeSemen volume< 1 cc< 1 cc

GonadotropinsGonadotropins TRUSTRUS

Semen volumeSemen volume>> 1 cc 1 cc

Dilated SV’sDilated SV’s

Testis biopsy/Testis biopsy/sperm retrievalsperm retrieval

NormalNormalspermatogenesisspermatogenesis ICSIICSI

Vasogram/Vasogram/SV gramSV gram

EjaculatoryEjaculatoryductduct

obstructionobstruction

TUREDTUREDballoon dilationballoon dilation

FSHFSH< 2x normal< 2x normal

FSHFSH>> 2x normal 2x normal

GeneticGeneticevaluationevaluation

Testis biopsy/Testis biopsy/sperm retrievalsperm retrieval

No spermNo sperm Decreased spermDecreased spermproductionproduction

NormalNormalspermatogenesisspermatogenesis

TIDTIDadoptionadoption

TESE/ICSITESE/ICSI VasogramVasogramSpermSperm

retrieval/retrieval/ICSIICSI

EpididymalEpididymalexploration/VEexploration/VE

+/- sperm+/- spermretrievalretrieval

> 15 years> 15 years

Sperm retrieval/Sperm retrieval/ICSIICSI

CBAVDCBAVD

CF testingCF testing

Sperm retrieval/Sperm retrieval/ICSIICSI

Kolettis PN. J Androl 23:293-305, 2002.Kolettis PN. J Androl 23:293-305, 2002.

CF - 1/2500 births: carriers 1/25 CF - 1/2500 births: carriers 1/25

95% - “Wolffian duct abnormalities”95% - “Wolffian duct abnormalities”

CF - 1/2500 births: carriers 1/25 CF - 1/2500 births: carriers 1/25

95% - “Wolffian duct abnormalities”95% - “Wolffian duct abnormalities”

Page 37: Fertiliteitsdiagnostiek  anno 2011

EVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIAEVALUATION OF AZOOSPERMIA

AzoospermiaAzoospermia

VasectomyVasectomyEndocrineEndocrineevaluationevaluation

<< 15 years 15 years

Vas reversalVas reversal

HypogonadotropicHypogonadotropichypogonadismhypogonadism

Semen volumeSemen volume< 1 cc< 1 cc

GonadotropinsGonadotropins TRUSTRUS

Semen volumeSemen volume>> 1 cc 1 cc

Dilated SV’sDilated SV’s

Testis biopsy/Testis biopsy/sperm retrievalsperm retrieval

NormalNormalspermatogenesisspermatogenesis ICSIICSI

Vasogram/Vasogram/SV gramSV gram

EjaculatoryEjaculatoryductduct

obstructionobstruction

TUREDTUREDballoon dilationballoon dilation

FSHFSH< 2x normal< 2x normal

FSHFSH>> 2x normal 2x normal

GeneticGeneticevaluationevaluation

Testis biopsy/Testis biopsy/sperm retrievalsperm retrieval

No spermNo sperm Decreased spermDecreased spermproductionproduction

NormalNormalspermatogenesisspermatogenesis

TIDTIDadoptionadoption

TESE/ICSITESE/ICSI VasogramVasogramSpermSperm

retrieval/retrieval/ICSIICSI

EpididymalEpididymalexploration/VEexploration/VE

+/- sperm+/- spermretrievalretrieval

> 15 years> 15 years

Sperm retrieval/Sperm retrieval/ICSIICSI

CBAVDCBAVD

CF testingCF testing

Sperm retrieval/Sperm retrieval/ICSIICSI

Kolettis PN. J Androl 23:293-305, 2002.Kolettis PN. J Androl 23:293-305, 2002.

Page 38: Fertiliteitsdiagnostiek  anno 2011

Grade I:

Grade II:

Grade III:

Testicular microlithiasisTesticular microlithiasis tumors tumors

varicocelevaricocele

Page 39: Fertiliteitsdiagnostiek  anno 2011

Environmental factors

Male Fertility

Physicallighttemperatureradiationelectromagnetic fields

Socio-economicnutritionstarvationoccupationlife styleBehavioral

psychologic stressdrug addiction: coffee, smoking, alcoholextreme weight lossphysical stress: competitive sports

Biologicalinfections

viralbacterial....

Chemicalmedicationheavy metals

(Pb, Cd,...)pesticides

Page 40: Fertiliteitsdiagnostiek  anno 2011

Occupational heat exposure and male fertility

Occupational heat exposure and male fertility

Cumulative conception rate according to the male partners

exposure to heat. Exposed = exposed to heat or

seated in a vehicle for more than 3 hours per day.

Thonneau et al, Lancet, 1996, 347, 204-5 and Bujan et al, 2000, Hum Reprod, 15, 1355 - 7.

Page 41: Fertiliteitsdiagnostiek  anno 2011

Cell phones & oxidative stress

Agarwal, RBMOnline, 15, 266, 2007

Page 42: Fertiliteitsdiagnostiek  anno 2011

ConclusieConclusie

Accurate diagnose blijft belangrijkAccurate diagnose blijft belangrijk AnamneseAnamnese Klinisch onderzoekKlinisch onderzoek Speciale onderzoekenSpeciale onderzoeken

Minimale onderzoeken // Maximaal rendementMinimale onderzoeken // Maximaal rendement

Infertiliteit Infertiliteit ≠ ≠ IVF & ICSIIVF & ICSI

Page 43: Fertiliteitsdiagnostiek  anno 2011

Genk IVF team

Page 44: Fertiliteitsdiagnostiek  anno 2011